BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16140543)

  • 1. Colorectal cancer after orthotopic liver transplantation.
    Silva MA; Jambulingam PS; Mirza DF
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer in post-liver transplant recipients.
    Sint Nicolaas J; Tjon AS; Metselaar HJ; Kuipers EJ; de Man RA; van Leerdam ME
    Dis Colon Rectum; 2010 May; 53(5):817-21. PubMed ID: 20389217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
    Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for cancer after liver transplantation.
    Vallejo GH; Romero CJ; de Vicente JC
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):87-99. PubMed ID: 15979889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
    Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with the development of skin cancer after liver transplantation.
    Mithoefer AB; Supran S; Freeman RB
    Liver Transpl; 2002 Oct; 8(10):939-44. PubMed ID: 12360438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
    Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT
    Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence after immunosuppressive treatment following kidney transplantation.
    Andrés A
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention and screening in primary sclerosing cholangitis.
    Kitiyakara T; Chapman RW
    Postgrad Med J; 2008 May; 84(991):228-37. PubMed ID: 18508979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U; Bergquist A
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo malignancies following liver transplantation: impact and recommendations.
    Herrero JI
    Liver Transpl; 2009 Nov; 15 Suppl 2():S90-4. PubMed ID: 19877025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
    Beaugerie L; Sokol H; Seksik P
    Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E; Remzi FH; Manilich E; Preen M; Shen B; Fazio VW
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.